Ronald Hunt - Jul 1, 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role: Director, 10%+ Owner
Signature: /s/ Frank J. Lanza, Attorney-in-Fact
Stock symbol: HARP
Transactions as of: Jul 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/6/2023, 06:36 PM
Previous filing: Jun 23, 2023
Next filing: Oct 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HARP	Common Stock	Award	$0	+18.7K	+102.03%	$0.00	36.9K	Jul 1, 2023	Direct	F1
holding	HARP	Common Stock						914K	Jul 1, 2023	See Footnote	F2, F3
holding	HARP	Common Stock						2.24M	Jul 1, 2023	See Footnote	F4, F5
holding	HARP	8.000% Series A Redeemable Preferred Stock						10K	Jul 1, 2023	See Footnote	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). The fully vested RSUs were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500.
F2	These shares are held directly by New Leaf Biopharma Opportunities II, L.P. ("BPO-II"). The sole general partner of BPO-II is New Leaf BPO Associates II, L.P. ("NLBA-II"). The sole general partner of NLBA-II is New Leaf BPO Management II, L.L.C. ("BPO Management-II"). Each of NLBA-II and BPO Management-II disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLBA-II or BPO Management-II are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein.
F3	The Reporting Person, a board member of the Issuer, and Vijay K. Lathi (the "BPO-II Managing Directors") are managing directors of BPO Management-II and may each be deemed to have shared voting and investment power with respect to these securities. Each of the BPO-II Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
F4	These shares are held directly by New Leaf Ventures III, L.P. ("NLV-III"). The sole general partner of NLV-III is New Leaf Venture Associates III,L.P. ("NLVA-III"). The sole general partner of NLVA-III is New Leaf Venture Management III, L.L.C. ("Management-III"). Each of NLVA-III and Management-III disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLVA-III or Management-III are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein.
F5	The Reporting Person, a board member of the Issuer, and Vijay K. Lathi (the "NLV-III Managers") are managing directors of Management-III and may be deemed to have shared voting and investment power with respect to these securities. Each of the NLV-III Managers disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.